Cutler Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$4.22M	Buy	15,800 +2,300	+17%	+$542K	2.13%	6
2023 Q4	$3.12M	Buy	13,500 +3,200	+31%	+$560K	0.43%	71
2023 Q3	$1.5M	Buy	10,300 +3,400	+49%	+$640K	0.24%	155
2023 Q2	$1.59M	Buy	6,900 +2,800	+68%	+$758K	0.38%	97
2023 Q1	$993K	Buy	+4,100	New	+$1.12M	0.16%	204
2022 Q4	–	Sell	-50	Closed	-$4.89K	–	5040
2022 Q3	$3K	Sell	50 -2,465	-98%	-$171K	﹤0.01%	3986
2022 Q2	$180K	Sell	2,515 -562	-18%	-$41.3K	0.02%	1077
2022 Q1	$301K	Buy	3,077 +1,507	+96%	+$127K	0.03%	939
2021 Q4	$133K	Sell	1,570 -230	-13%	-$18.9K	0.01%	1633
2021 Q3	$143K	Buy	1,800 +260	+17%	+$22.5K	0.01%	1612
2021 Q2	$150K	Buy	1,540 +640	+71%	+$75.8K	0.01%	1547
2021 Q1	$105K	Buy	900 +700	+350%	+$81.6K	0.01%	1738
2020 Q4	$22K	Sell	200 -3,000	-94%	-$367K	﹤0.01%	2623
2020 Q3	$379K	Buy	3,200 +2,018	+171%	+$219K	0.04%	624
2020 Q2	$133K	Sell	1,182 -318	-21%	-$31.3K	0.01%	1119
2020 Q1	$100K	Buy	1,500 +95	+7%	+$7.92K	0.01%	1331
2019 Q4	$128K	Sell	1,405 -300	-18%	-$29.1K	0.01%	1066
2019 Q3	$147K	Buy	1,705 +1,162	+214%	+$109K	0.02%	852
2019 Q2	$56K	Sell	543 -2,955	-84%	-$317K	0.01%	1470
2019 Q1	$438K	Buy	+3,498	New	+$435K	0.06%	359
2018 Q4	–	Sell	-2,666	Closed	-$413K	–	4520
2018 Q3	$570K	Buy	2,666 +1,666	+167%	+$418K	0.05%	424
2018 Q2	$279K	Buy	+1,000	New	+$176K	0.03%	646
2017 Q2	–	Sell	-547	Closed	-$8K	–	6918
2017 Q1	$8K	Hold	547	–	–	﹤0.01%	4280
2016 Q4	$8K	Hold	547	–	–	﹤0.01%	4440
2016 Q3	$6K	Sell	547 -1	-0.2%	-$10	﹤0.01%	4772
2016 Q2	$4K	Hold	548	–	–	﹤0.01%	5157
2016 Q1	$4K	Buy	548 +47	+9%	+$393	﹤0.01%	5053
2015 Q4	$6K	Buy	+501	New	+$13.7K	﹤0.01%	4714